奥泰生物: 关于开立闲置募集资金现金管理专用结算账户的公告

Core Viewpoint - The company has approved the use of temporarily idle raised funds for cash management, allowing a maximum balance of up to RMB 480 million to be invested in high-safety, liquid financial products with a maturity of no more than 12 months [1] Group 1: Cash Management Account - The company has opened a dedicated settlement account for cash management of idle raised funds at CITIC Bank Hangzhou Economic and Technological Development Zone Branch [2] - This account will only be used for cash management of idle raised funds and will not be used for non-raised funds or other purposes [2] Group 2: Investment Risk and Control Measures - The investment is subject to market fluctuations, and actual returns are unpredictable [2] - The company will adhere to relevant regulations and internal management measures to ensure the safety of funds and effective risk control [2][3] Group 3: Impact on Daily Operations - The establishment of the cash management account will not affect the construction of investment projects or normal operations, ensuring the safety of raised funds [3] - Utilizing temporarily idle funds for cash management can enhance the efficiency of fund usage, thereby increasing investment returns and shareholder value [3]